Regulation of ventral hippocampal system function
腹侧海马系统功能的调节
基本信息
- 批准号:8073091
- 负责人:
- 金额:$ 33.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAffectAgonistAnimal ModelAttentionAttenuatedAutopsyBehaviorBehavioralBrain regionChemicalsCognitiveCognitive deficitsComplexDataDeep Brain StimulationDevelopmentDiseaseDopamineFrequenciesFunctional disorderGlutamatesGoalsHippocampus (Brain)HumanHyperactive behaviorImageInterneuronsLearningMedialMediatingMemoryMental disordersMethodsMidbrain structureModelingNeurobiologyNeuronsNucleus AccumbensOperative Surgical ProceduresOutputParvalbuminsPathologyPatientsPharmaceutical PreparationsPharmacological TreatmentPopulationPrefrontal CortexPrincipal InvestigatorPropertyPsychotic DisordersRattusRecruitment ActivityRegulationReportingRestRodent ModelRoleSalineSchizophreniaSecondary toSignal TransductionStructureSymptomsSystemTemporal LobeTemporal Lobe EpilepsyTherapeuticTherapeutic AgentsTherapeutic StudiesToxic effectWorkattenuationbasebrain pathwaydopamine systemdriving forcegamma-Aminobutyric Acidhuman dataimprovedinformation processingmemory recallmesolimbic systemneurochemistryneuron developmentneurophysiologyneuropsychiatryneurotransmissionnew therapeutic targetnovelprogramspsychostimulantreceptorresponsetransmission process
项目摘要
DESCRIPTION (provided by applicant): Schizophrenia is a devastating psychiatric condition that affects approximately 0.4-1% of the US population. Substantial convergent evidence from drug studies, therapeutic treatments, and human imaging studies demonstrate that psychosis in schizophrenia is associated with a dysregulation of subcortical dopamine system function. This dopamine hypothesis of schizophrenia has one major caveat in that there appears to be no specific pathology in the midbrain dopamine system itself. Thus it is likely that it is the afferent regulation of the dopamine system that is dysfunctional in schizophrenia. Two such inputs are the medial prefrontal cortex (thought to be largely associated with cognitive deficits) and the hippocampus, a temporal lobe structure principally associated with learning and memory. Alterations in hippocampal structure and function in schizophrenia are consistently demonstrated in postmortem and neuro-imaging studies. Furthermore, there is increasing evidence for baseline hippocampal hyperactivity in human schizophrenia patients that is correlated with levels of psychosis. Consistent with this, we have recently reported baseline hyperactivity in the ventral hippocampus in a developmental disruption rodent model, namely MAM G17, that appears to be the driving force behind the dopamine hyperfunction in this model. Thus, attenuation of ventral hippocampal output may act to normalize dopamine transmission and may provide a novel therapeutic target. We plan to examine this model utilizing distinct approaches aimed specifically at modulating ventral hippocampal activity along the following Specific Aims: 1) Examine potential novel methods for regulating vHipp function in MAM and saline rats, 2) Determine how these methods for attenuating vHipp activity alter dopamine system function in MAM and saline rats, and 3) Determine whether attenuating vHipp system function can reverse behavioral deficits associated with schizophrenia in the MAM model. Examining the functional interactions among these systems and how disruption within this circuit affects information processing, neurochemistry and behavior is central to our ultimate goal of identifying new and improved therapeutic agents.
描述(由申请人提供):精神分裂症是一种毁灭性的精神病疾病,影响约0.4-1%的美国人口。来自药物研究,治疗治疗和人类成像研究的大量收敛证据表明,精神分裂症的精神病与皮质下多巴胺系统功能的失调有关。这种精神分裂症的多巴胺假说有一个主要的警告,因为中脑多巴胺系统本身似乎没有特定的病理。因此,精神分裂症中功能失调的多巴胺系统的传入调节很可能。两个这样的输入是内侧前额叶皮层(被认为与认知缺陷很大程度上相关)和海马,这是一种颞叶结构,主要与学习和记忆有关。在验尸和神经成像研究中,始终证明了海马结构和精神分裂症功能的改变。此外,与精神病水平相关的人类精神分裂症患者的基线海马过度活动有越来越多的证据。与此一致,我们最近报道了在发育破坏啮齿动物模型(即MAM G17)中,腹侧海马中的基线多动症,这似乎是该模型中多巴胺过度功能背后的驱动力。因此,腹侧海马输出的衰减可能起作用以使多巴胺传播正常化,并可能提供新颖的治疗靶标。 我们计划检查该模型采用旨在专门用于调节沿以下特定目的调节腹侧海马活动的不同方法:1)检查调节MAM和盐碱大鼠VHIPP功能的潜在新方法,2)确定这些方法如何减弱VHIPP活性在MAM和盐水中的延伸,并确定vhipp的行为是否能够改善vhipt的功能,并确定vhipt的功能,并确定nipt vhipt的功能,3) MAM模型中的精神分裂症。检查这些系统之间的功能相互作用以及该电路中的破坏如何影响信息处理,神经化学和行为对于我们确定新的和改进的治疗剂的最终目标至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Lodge其他文献
Daniel Lodge的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Lodge', 18)}}的其他基金
Aberrant dopamine system function in a rodent model of perimenopause: relevance to psychosis
围绝经期啮齿动物模型中多巴胺系统功能异常:与精神病的相关性
- 批准号:
10585490 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别:
Mechanisms contributing to co-morbid psychosis in Alzheimer's disease
阿尔茨海默病共病精神病的机制
- 批准号:
10012453 - 财政年份:2020
- 资助金额:
$ 33.08万 - 项目类别:
The Orexin System as a Target for PTSD and Comorbid Psychosis
食欲素系统作为创伤后应激障碍和共病精神病的目标
- 批准号:
10618914 - 财政年份:2020
- 资助金额:
$ 33.08万 - 项目类别:
The Orexin System as a Target for PTSD and Comorbid Psychosis
食欲素系统作为创伤后应激障碍和共病精神病的目标
- 批准号:
10454782 - 财政年份:2020
- 资助金额:
$ 33.08万 - 项目类别:
Mechanisms contributing to co-morbid psychosis in Alzheimer's disease
阿尔茨海默病共病精神病的机制
- 批准号:
10293545 - 财政年份:2020
- 资助金额:
$ 33.08万 - 项目类别:
The Orexin System as a Target for PTSD and Comorbid Psychosis
食欲素系统作为创伤后应激障碍和共病精神病的目标
- 批准号:
9891460 - 财政年份:2020
- 资助金额:
$ 33.08万 - 项目类别:
Mechanisms contributing to co-morbid psychosis in Alzheimer's disease
阿尔茨海默病共病精神病的机制
- 批准号:
10514575 - 财政年份:2020
- 资助金额:
$ 33.08万 - 项目类别:
Adiponectin regulation of the mesolimbic dopamine system
脂联素对中脑边缘多巴胺系统的调节
- 批准号:
8228413 - 财政年份:2012
- 资助金额:
$ 33.08万 - 项目类别:
Adiponectin regulation of the mesolimbic dopamine system
脂联素对中脑边缘多巴胺系统的调节
- 批准号:
8432434 - 财政年份:2012
- 资助金额:
$ 33.08万 - 项目类别:
Regulation of ventral hippocampal system function
腹侧海马系统功能的调节
- 批准号:
9304377 - 财政年份:2010
- 资助金额:
$ 33.08万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:82101697
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Isolating the role of endogenous mu-opioid activity in the VTA during natural reward
分离自然奖赏期间 VTA 中内源性 mu-阿片活性的作用
- 批准号:
10749349 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别:
Targeting GPR84 to Overcome Macrophage Mediated Resistance to Immunotherapy
靶向 GPR84 克服巨噬细胞介导的免疫治疗耐药性
- 批准号:
10660122 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别:
CLEC7A in microglia biology and Alzheimer's disease
CLEC7A 在小胶质细胞生物学和阿尔茨海默病中的作用
- 批准号:
10659940 - 财政年份:2023
- 资助金额:
$ 33.08万 - 项目类别: